Last Price$70.5(2.1%)
Market Cap$13.4B
1Y Forward Revenue growth
11.4%
1Y Forward EPS growth
40.4%
Last EPS & EPS Surprise
$0.65
21.7% beat
Last 10 Earnings
7 Beat / 3 Miss
BMRN Revenue and EPS Expectations
Annual
Quarterly
| Dec'22 | Dec'23 | Dec'24 | Dec'25 | Dec'26 | Dec'27 | Dec'28 | Dec'29 | |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | 13.5% | 15.4% | 18.0% | 11.4% | 9.8% | 8.4% | 5.5% | 4.2% |
| EPS growth | N/A | 17.1% | 139.3% | 40.4% | 29.8% | 21.8% | 22.4% | 11.3% |
BMRN Earnings Surprises
Crunching data... Almost there!
BMRN Earnings History
| Mar'15 | Jun'15 | Sep'15 | Dec'15 | Mar'16 | Jun'16 | Sep'16 | Dec'16 | Mar'17 | Jun'17 | Sep'17 | Dec'17 | Mar'18 | Jun'18 | Sep'18 | Dec'18 | Mar'19 | Jun'19 | Sep'19 | Dec'19 | Mar'20 | Jun'20 | Sep'20 | Dec'20 | Mar'21 | Jun'21 | Sep'21 | Dec'21 | Mar'22 | Jun'22 | Sep'22 | Dec'22 | Mar'23 | Jun'23 | Sep'23 | Dec'23 | Mar'24 | Jun'24 | Sep'24 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue actual | $203.3M | $250.5M | $208.9M | $227.9M | $236.7M | $300.1M | $279.9M | $300.1M | $303.7M | $317.4M | $334.1M | $358.3M | $373.4M | $372.8M | $391.7M | $353.2M | $400.7M | $387.8M | $461.1M | $454.4M | $502.1M | $429.5M | $476.8M | $452.1M | $486.0M | $501.7M | $408.7M | $449.8M | $519.4M | $533.8M | $505.3M | $537.5M | $592.9M | $594.6M | $586.0M | $646.2M | $648.8M | $708.7M | $745.7M | $747.3M |
| Revenue estimate | $250.5M | $250.5M | $250.5M | $250.5M | $375.2M | $375.2M | $375.2M | $375.2M | $945.0M | $945.0M | $945.0M | $945.0M | $253.9M | $253.9M | $253.9M | $253.9M | $390.0M | $415.9M | $455.8M | $457.9M | $468.6M | $418.6M | $457.4M | $439.3M | $446.3M | $448.3M | $435.3M | $442.4M | $511.0M | $520.2M | $518.5M | $537.6M | $570.4M | $595.2M | $603.8M | $638.8M | $651.8M | $664.0M | $703.4M | $712.3M |
| Revenue surprise | 18.9% | 0.0% | 16.6% | 9.0% | 36.9% | 20.0% | 25.4% | 20.0% | 67.9% | 66.4% | 64.6% | 62.1% | 47.1% | 46.8% | 54.2% | 39.1% | 2.8% | 6.8% | 1.2% | 0.8% | 7.1% | 2.6% | 4.2% | 2.9% | 8.9% | 11.9% | 6.1% | 1.7% | 1.6% | 2.6% | 2.5% | 0.0% | 4.0% | 0.1% | 3.0% | 1.2% | 0.5% | 6.7% | 6.0% | 4.9% |
| EPS actual | ($0.43) | ($0.51) | ($0.57) | $0.43 | ($0.53) | ($2.61) | ($0.26) | ($0.53) | ($0.09) | ($0.21) | ($0.07) | ($0.29) | ($0.25) | ($0.09) | ($0.07) | ($0.02) | ($0.32) | ($0.21) | $0.31 | $0.08 | $0.45 | ($0.16) | $4.33 | $0.12 | $0.10 | $0.07 | ($0.20) | ($0.32) | $0.63 | $0.15 | ($0.04) | ($0.00) | $0.27 | $0.30 | $0.21 | $0.11 | $0.47 | $0.56 | $0.57 | $0.65 |
| EPS estimate | ($0.63) | ($0.63) | ($0.63) | ($0.63) | ($1.15) | ($1.15) | ($1.15) | ($1.15) | ($0.42) | ($0.42) | ($0.42) | ($0.42) | ($0.10) | ($0.10) | ($0.10) | ($0.10) | ($0.20) | ($0.11) | $0.06 | ($0.04) | $0.03 | ($0.11) | $0.25 | ($0.17) | ($0.09) | ($0.11) | ($0.25) | ($0.36) | $0.21 | $0.03 | ($0.01) | ($0.06) | $0.16 | $0.21 | $0.22 | $0.20 | $0.31 | $0.36 | $0.53 | $0.53 |
| EPS surprise | 31.7% | 19.0% | 9.5% | 168.3% | 53.9% | 127.0% | 77.4% | 53.9% | 77.5% | 50.0% | 83.0% | 31.0% | 150.0% | 5.1% | 28.9% | 79.5% | 60.8% | 98.8% | 425.9% | 319.2% | 1,349.1% | 42.1% | 1,632.0% | 171.4% | 212.1% | 164.1% | 20.0% | 11.7% | 196.5% | 355.6% | 198.3% | 97.8% | 74.1% | 41.9% | 4.3% | 44.2% | 50.7% | 56.5% | 7.4% | 21.7% |
FAQ
1. What is BioMarin Pharmaceutical Inc. (BMRN) 1-year forward revenue growth estimate?
BioMarin Pharmaceutical Inc. (BMRN) 1-year forward revenue growth is estimated at 11.4%.
2. What is BioMarin Pharmaceutical Inc. (BMRN) 1-year forward EPS growth estimate?
BioMarin Pharmaceutical Inc. (BMRN) 1-year forward EPS growth is estimated at 40.4%.
3. What was BioMarin Pharmaceutical Inc. (BMRN) last EPS, and was there a surprise?
BioMarin Pharmaceutical Inc. (BMRN) last reported EPS was $0.65, with a 21.7% beat.
4. What is BioMarin Pharmaceutical Inc. (BMRN) performance across the last 10 earnings reports?
BioMarin Pharmaceutical Inc. (BMRN) had 7 beats and 3 misses in its last 10 earnings reports.